Kristi Key+FollowCRISPR T Cells Take on Tough CancerMetastatic colorectal cancer just got a new challenger: CRISPR-edited T cells! At AACR25, Emil Lou showed off early data where they used CRISPR to target the CISH checkpoint in patients who didn’t respond to other treatments. It’s wild to see gene editing moving from the lab to real people, and it could mean hope for folks with stubborn cancers. Science is seriously leveling up! #CRISPR #CancerResearch #ColorectalCancer #AACR25 #Immunotherapy #Health230Share